For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $71.68 in the prior trading day, Dolby Laboratories Inc (NYSE: DLB) closed at $72.1, up 0.59%. In other words, the price has increased by $0.59 from its previous closing price. On the day, 0.65 million shares were traded. DLB stock price reached its highest trading level at $72.135 during the session, while it also had its lowest trading level at $70.836.
Ratios:
Our goal is to gain a better understanding of DLB by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.78. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 3.44. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’25 when Revankar Shriram sold 7,000 shares for $74.92 per share. The transaction valued at 524,440 led to the insider holds 70,435 shares of the business.
SHRIRAM REVANKAR bought 7,000 shares of DLB for $524,440 on Aug 22 ’25. On Aug 12 ’25, another insider, YEAMAN KEVIN J, who serves as the President and CEO of the company, sold 25,000 shares for $72.31 each. As a result, the insider received 1,807,828 and left with 114,725 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DLB now has a Market Capitalization of 6910366720 and an Enterprise Value of 6259664896. As of this moment, Dolby’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.49, and their Forward P/E ratio for the next fiscal year is 16.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.13 while its Price-to-Book (P/B) ratio in mrq is 2.65. Its current Enterprise Value per Revenue stands at 4.647 whereas that against EBITDA is 16.63.
Stock Price History:
The Beta on a monthly basis for DLB is 0.92, which has changed by 0.02009058 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, DLB has reached a high of $89.66, while it has fallen to a 52-week low of $68.24. The 50-Day Moving Average of the stock is -2.80%, while the 200-Day Moving Average is calculated to be -6.66%.
Shares Statistics:
The stock has traded on average 392.25K shares per day over the past 3-months and 521510 shares per day over the last 10 days, according to various share statistics. A total of 61.12M shares are outstanding, with a floating share count of 60.39M. Insiders hold about 36.99% of the company’s shares, while institutions hold 61.19% stake in the company. Shares short for DLB as of 1755216000 were 1511607 with a Short Ratio of 3.85, compared to 1752537600 on 1447475. Therefore, it implies a Short% of Shares Outstanding of 1511607 and a Short% of Float of 3.6900000000000004.
Dividends & Splits
In the trailing 12 months, DLB’s forward annual dividend rate was 1.32, compared to 1.32 this year. Against a Trailing Annual Dividend Yield of 0.01841518The stock’s 5-year Average Dividend Yield is 1.3.
Earnings Estimates
Its stock is currently analyzed by 4.0 different market analysts. The consensus estimate for the next quarter is $1.15, with high estimates of $1.23 and low estimates of $0.95.
Analysts are recommending an EPS of between $3.98 and $3.95 for the fiscal current year, implying an average EPS of $3.96. EPS for the following year is $4.26, with 4.0 analysts recommending between $4.36 and $4.1.
Revenue Estimates
4 analysts predict $306.19M in revenue for the current quarter. It ranges from a high estimate of $310M to a low estimate of $303.46M. As of the current estimate, Dolby Laboratories Inc’s year-ago sales were $304.81MFor the next quarter, 4 analysts are estimating revenue of $369.26M. There is a high estimate of $380.4M for the next quarter, whereas the lowest estimate is $343.48M.
A total of 4 analysts have provided revenue estimates for DLB’s current fiscal year. The highest revenue estimate was $1.35B, while the lowest revenue estimate was $1.35B, resulting in an average revenue estimate of $1.35B. In the same quarter a year ago, actual revenue was $1.27BBased on 4 analysts’ estimates, the company’s revenue will be $1.42B in the next fiscal year. The high estimate is $1.46B and the low estimate is $1.39B.
